Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2018-000411-24Phase 4Completed
Phase 4 trial of tranexamic acid, sponsored by Centre Hospitalier Universitaire de Brest. Primary endpoint: Reduction of bleeding. Started Mar 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2018-000411-24.